Aimed Bio Inc. (KOSDAQ:0009K0)
62,700
-2,600 (-3.98%)
At close: Mar 9, 2026
Aimed Bio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 24,893 | 4,488 | 1,463 | 2,872 |
| Short-Term Investments | 142,960 | 31,030 | 16,618 | 3,146 |
| Cash & Short-Term Investments | 167,853 | 35,519 | 18,081 | 6,018 |
| Cash Growth | 828.36% | 96.45% | 200.42% | - |
| Accounts Receivable | 865.13 | - | - | 45.46 |
| Other Receivables | 865.13 | 459.85 | 659.65 | 388.9 |
| Receivables | 1,730 | 459.85 | 659.65 | 434.36 |
| Other Current Assets | 1,048 | 248.91 | 68.76 | 130.83 |
| Total Current Assets | 170,632 | 36,227 | 18,809 | 6,584 |
| Property, Plant & Equipment | 3,389 | 1,469 | 2,353 | 2,157 |
| Long-Term Investments | 4,107 | 6,537 | 220.88 | 1,305 |
| Other Intangible Assets | 3,350 | 1,742 | 334.61 | 325.41 |
| Other Long-Term Assets | 7,621 | 1,166 | 714.93 | 558.24 |
| Total Assets | 189,099 | 47,141 | 22,432 | 10,929 |
| Accrued Expenses | 360.1 | 181.92 | 197.61 | 63.69 |
| Current Portion of Leases | 381.19 | 425.57 | 525.67 | 490.95 |
| Current Unearned Revenue | 468.73 | 795.46 | 1,295 | 140.79 |
| Other Current Liabilities | 3,595 | 725.35 | 2,404 | 227.48 |
| Total Current Liabilities | 6,930 | 2,128 | 4,423 | 922.9 |
| Long-Term Leases | 344.77 | - | 375.01 | 521.93 |
| Other Long-Term Liabilities | 1,281 | 195.6 | 32.43 | 28.98 |
| Total Liabilities | 8,556 | 2,324 | 4,830 | 1,474 |
| Common Stock | 57,726 | 17,735 | 17,735 | 16,716 |
| Additional Paid-In Capital | 232,228 | 8,979 | 8,979 | 4,830 |
| Retained Earnings | -112,673 | -26,436 | -23,132 | -14,109 |
| Comprehensive Income & Other | 559.35 | 3,082 | 3,112 | 2,007 |
| Total Common Equity | 177,840 | 3,360 | 6,694 | 9,443 |
| Minority Interest | 3.75 | 7.5 | 15.66 | 12.29 |
| Shareholders' Equity | 177,844 | 44,817 | 17,602 | 9,456 |
| Total Liabilities & Equity | 186,400 | 47,141 | 22,432 | 10,929 |
| Total Debt | 1,107 | 425.57 | 900.68 | 1,013 |
| Net Cash (Debt) | 166,746 | 35,093 | 17,180 | 5,006 |
| Net Cash Growth | 870.59% | 104.27% | 243.21% | - |
| Net Cash Per Share | 4130.78 | 989.35 | 503.02 | 149.73 |
| Filing Date Shares Outstanding | 57.73 | 35.47 | 35.47 | 33.43 |
| Total Common Shares Outstanding | 57.73 | 35.47 | 35.47 | 33.43 |
| Working Capital | 163,702 | 34,099 | 14,386 | 5,661 |
| Book Value Per Share | 3080.76 | 94.73 | 188.73 | 282.47 |
| Tangible Book Value | 174,490 | 1,619 | 6,360 | 9,118 |
| Tangible Book Value Per Share | 3022.72 | 45.63 | 179.29 | 272.73 |
| Machinery | 2,738 | 2,469 | 2,329 | 1,895 |
Source: S&P Capital IQ. Standard template. Financial Sources.